Mark Harmon

Mark Harmon

Ask VT AI
View News Summary
  • Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
  • European tech stocks gain momentum, Australian small-caps outperform, and Canadian firms focus on scalable, subscription-based models for global expansion.
  • The federal government shutdown is disrupting the U.S. housing market, halting key programs and causing delays in home sales, especially in areas with high concentrations of federal workers.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
  • European tech stocks gain momentum, Australian small-caps outperform, and Canadian firms focus on scalable, subscription-based models for global expansion.
  • The federal government shutdown is disrupting the U.S. housing market, halting key programs and causing delays in home sales, especially in areas with high concentrations of federal workers.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Mark Harmon